These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4546694)

  • 41. [Evaluation of amikacin in gynecological and obstetric field (author's transl)].
    Yuasa M
    Jpn J Antibiot; 1974 Jun; 27(3):377-81. PubMed ID: 4612187
    [No Abstract]   [Full Text] [Related]  

  • 42. [Studies on the toxicity of amikacin (BB-K8). Chronic toxicity in dogs (author's transl)].
    Matsuzaki M; Yoshida A; Akutsu S; Nakamura K; Sekino M
    Jpn J Antibiot; 1975 Aug; 28(4):485-524. PubMed ID: 1160144
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical experience of amikacin eye lotion (author's transl)].
    Sone Y; Suzuki A; Yamazaki T; Murata M; Komori T; Maekawa I
    Jpn J Antibiot; 1981 Jul; 34(7):1058-62. PubMed ID: 7321183
    [No Abstract]   [Full Text] [Related]  

  • 44. [Teratological studies of amikacin (BB-K8) in mice and rats (author's transl)].
    Matsuzaki M; Akutsu S; Mukogawa H; Shimamura T
    Jpn J Antibiot; 1975 Jun; 28(3):372-84. PubMed ID: 1152291
    [No Abstract]   [Full Text] [Related]  

  • 45. [Evaluation of amikacin in obstetric and gynecological fields (author's transl)].
    Matsuda S; Mori S; Tanno M; Kashiwagura T
    Jpn J Antibiot; 1974 Oct; 27(5):633-6. PubMed ID: 4617009
    [No Abstract]   [Full Text] [Related]  

  • 46. [Studies on the toxicity of amikacin (BB-K8).II. Chronic toxicity in rats (author's transl)].
    Matsuzaki M; Nakamura K; Yoshida A; Sekino M; Iimo K
    Jpn J Antibiot; 1975 Aug; 28(4):435-57. PubMed ID: 1160142
    [No Abstract]   [Full Text] [Related]  

  • 47. Management of common bacterial infections of the skin.
    Bernard P
    Curr Opin Infect Dis; 2008 Apr; 21(2):122-8. PubMed ID: 18317033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pharmacological studies on BB-K8 (author's transl)].
    Aratani H; Yamanaka Y; Kono S; Tateishi H
    Jpn J Antibiot; 1974 Apr; 27(2):202-11. PubMed ID: 4546642
    [No Abstract]   [Full Text] [Related]  

  • 49. [Studies on the toxicity of amikacin (BB-K8), I. Acute toxicity and subacute toxicity in rats (author's transl)].
    Matsuzaki M; Nakamura K; Akutsu S; Sekino M; Hirata A
    Jpn J Antibiot; 1975 Aug; 28(4):415-34. PubMed ID: 1160141
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pharmacological studies of amikacin (BB-K8) (author's transl)].
    Matsuzaki M; Onodera K; Okazaki I; Nakajima A; Akima T
    Jpn J Antibiot; 1975 Jun; 28(3):385-400. PubMed ID: 1152292
    [No Abstract]   [Full Text] [Related]  

  • 51. [Evaluation of amikacin intravenous therapy in pediatrics (author's transl)].
    Nakazawa S; Sato H; Fujii N; Kojima S; Narita A; Chikaoka H; Oka S
    Jpn J Antibiot; 1980 Oct; 33(10):1104-10. PubMed ID: 7206214
    [No Abstract]   [Full Text] [Related]  

  • 52. Bacteriology and urinary examination in impetigo contagiosa. A prospective study in a Swedish urban area.
    Bojs G; Juhlin I; Möller H
    Acta Derm Venereol; 1973; 53(6):481-6. PubMed ID: 4129598
    [No Abstract]   [Full Text] [Related]  

  • 53. [Therapeutic experience with 3',4'-dideoxykanamycin B (DKB) (author's transl)].
    Yamagishi M; Kojima K
    Jpn J Antibiot; 1974 Aug; 27(4):549-55. PubMed ID: 4436960
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical experience of amikacin intravenous drip infusion for digestive organ infection (author's transl)].
    Yokomori T; Hisataka H; Kaneko H; Owada S; Saito K; Watanabe M
    Jpn J Antibiot; 1981 Jun; 34(6):852-5. PubMed ID: 7289040
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical results in treatment of purulent dermatoses with amoxicillin (author's transl)].
    So Y; Doi A; Ohsato N; Oguchi M
    Jpn J Antibiot; 1976 Jan; 29(1):27-9. PubMed ID: 1263339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of ampicillin-dicloxacillin combination in pediatric field (author's transl].
    Nakazawa S; Sato H; Watanabe O; Fujii N; Chikaoka S
    Jpn J Antibiot; 1974 Apr; 27(2):135-40. PubMed ID: 4546612
    [No Abstract]   [Full Text] [Related]  

  • 57. [Staphylogenic etiology of Impetigo contagiosa].
    Holzegel K
    Dtsch Gesundheitsw; 1970 Sep; 25(37):1752-4. PubMed ID: 5203365
    [No Abstract]   [Full Text] [Related]  

  • 58. [Contribution to peroral antibiotic-free and sulfonamide-free therapy of chronic infectious skin disorders of different pathogenesis].
    Giss G
    Z Haut Geschlechtskr; 1965 Oct; 39(7):313-21. PubMed ID: 5893664
    [No Abstract]   [Full Text] [Related]  

  • 59. New findings in impetigo.
    Scillia T; Skehan M; Smith LG
    J Med Soc N J; 1974 Aug; 71(8):569-70. PubMed ID: 4604816
    [No Abstract]   [Full Text] [Related]  

  • 60. [Impetigo herpetiformis and PUVA-treatment (author's transl)].
    Lohrisch I; Heilmann S; Haustein UF
    Dermatol Monatsschr; 1979 Sep; 165(9):648-52. PubMed ID: 527745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.